Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

352

Participants

Timeline

Start Date

June 9, 2021

Primary Completion Date

April 20, 2023

Study Completion Date

April 20, 2023

Conditions
Psoriasis
Interventions
DRUG

Risankizumab

Subcutaneous injection

DRUG

Apremilast

Oral Tablets

Trial Locations (54)

15831

Dermatologische Gemeinschaftspraxis Mahlow /ID# 229434, Mahlow

20850

DermAssociates, LLC /ID# 229016, Rockville

22391

MENSINGDERMA research GmbH /ID# 229435, Hamburg

24148

DermaKiel Allergie und Haut Centrum /ID# 229630, Kiel

33134

Florida Academic Centers Research and Education /ID# 229235, Coral Gables

33770

Olympian Clinical Research - Largo /ID# 233792, Largo

34470

Renstar Medical Research /ID# 228946, Ocala

35205

Total Skin and Beauty Dermatology Center /ID# 233793, Birmingham

44106

University Hospitals Case Medical Center /ID# 229240, Cleveland

44793

Hautarztpraxis Dr. Niesmann und Dr. Othlinghaus /ID# 230245, Bochum

46256

Dawes Fretzin, LLC /ID# 229010, Indianapolis

48149

Universitaetsklinikum Muenster /ID# 229432, Munster

48346

Michigan Center for Research Company /ID# 229136, Clarkston

48455

Fachklinik Bad Bentheim /ID# 231504, Bad Bentheim

60008

Arlington Dermatology /ID# 228945, Rolling Meadows

60590

Universitaetsklinikum Frankfurt /ID# 229431, Frankfurt am Main

64506

MediSearch Clinical Trials /ID# 229269, Saint Joseph

66210

Epiphany Dermatology of Kansas LLC /ID# 229221, Overland Park

68516

Physician Research Collaboration, LLC /ID# 229225, Lincoln

76011

Arlington Research Center, Inc /ID# 229264, Arlington

77401

Bellaire Dermatology Associates /ID# 230118, Bellaire

85032

Alliance Dermatology and MOHs Center, PC /ID# 229224, Phoenix

85308

Advanced Research Associates - Glendale /ID# 229266, Glendale

91054

Universitaetsklinikum Erlangen /ID# 229433, Erlangen

97210

Oregon Dermatology and Research Center /ID# 233462, Portland

99202

Premier Clinical Research /ID# 229220, Spokane

1834111

HaEmek Medical Center /ID# 231901, Afula

3109601

Rambam Health Care Campus /ID# 229620, Haifa

4941492

Rabin Medical Center /ID# 229074, Haifa

5265601

The Chaim Sheba Medical Center /ID# 229075, Ramat Gan

95816-3300

UC Davis Health /ID# 229133, Sacramento

33613-1244

ForCare Clinical Research /ID# 229135, Tampa

48202-3046

Henry Ford Medical Center /ID# 229215, Detroit

68144-1105

Advanced Dermatology of the Midlands /ID# 229009, Omaha

08520

Psoriasis Treatment Center of Central New Jersey /ID# 228943, East Windsor

45324-2640

Wright State Physicians - Fairborn /ID# 230051, Fairborn

77004-8097

Center for Clinical Studies - Houston (Binz) /ID# 229263, Houston

Center for Clinical Studies - Houston (Binz) /ID# 229272, Houston

T3E 0B2

Beacon Dermatology Inc /ID# 230121, Calgary

V3R 6A7

Dr. Chih-ho Hong Medical Inc. /ID# 230337, Surrey

V3V 0C6

Enverus Medical Research /ID# 230480, Surrey

A1A 4Y3

Karma Clinical Trials /ID# 230339, St. John's

L8N 1Y2

Dermatrials Research /ID# 230119, Hamilton

L3Y 5G8

Dr. S.K. Siddha Medicine Professional Corporation /ID# 230416, Newmarket

N2J 1C4

K. Papp Clinical Research /ID# 230336, Waterloo

H2X 2V1

Innovaderm Research Inc. /ID# 230334, Montreal

G1V 4X7

Centre de Recherche dermatologique du Quebec Metropolitain /ID# 230478, Québec

07548

SRH Wald-Klinikum Gera /ID# 229445, Gera

01-817

High-Med Przychodnia Specjalistyczna /ID# 229023, Warsaw

02-962

Royalderm Agnieszka Nawrocka /ID# 228973, Warsaw

35-055

Uniwersytecki Szpital Kliniczny im. F. Chopina w Rzeszowie /ID# 229022, Rzeszów

80-546

Centrum Badan Klinicznych PI-House sp. z o.o. /ID# 229053, Gdansk

82-300

Centrum Kliniczno-Badawcze J.Brzezicki, B. Gornikiewicz-Brzezicka Lekarze Spolka /ID# 228971, Elblag

90-265

Dermed Centrum Medyczne Sp. z o.o /ID# 229051, Lodz

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY